Linden Capital

Linden Capital Partners is a Chicago-based private equity firm exclusively focused on the healthcare industry. Established in 2004, the firm dedicates substantial resources to developing exceptional middle-market healthcare and life science companies. Their investment strategy combines buyout and structured capital investments with a proprietary Value Creation Program (VCP), active board-level involvement, and engagement with operating partners to drive growth, operational improvements, and successful exits for their portfolio companies.

Founded in 2004, Linden Capital Partners has grown to become one of the country's largest dedicated healthcare private equity firms. The firm's model emphasizes partnership with management teams and actively engaged operating partners, a strategy they helped pioneer in private equity investing. Co-founders include Anthony B. Davis and Brian Miller, who have extensive experience in healthcare principal investing.

Linden Capital Partners' portfolio includes a diverse range of healthcare companies. Notable investments and areas of focus include Regenity Biosciences (formerly Collagen Matrix), a global developer and manufacturer of bioresorbable technologies, and BioIVT, a biospecimen and research services provider. The firm also invests in areas such as behavioral health, dental service organizations, healthcare IT (HCIT), multi-site providers, pharma services, medical devices, and diagnostics.

The firm's experienced team brings high-level expertise, integrated perspectives, and a deep network of industry relationships to its investments. This team includes investment professionals, operating partners, senior advisors, and human capital specialists, all working collaboratively to enhance the operational and strategic performance of their portfolio companies.